CareDx (CDNA) Net Margin (2013 - 2026)

CareDx (CDNA) posted Net Margin of 83.83% for Q2 2026, up 3412.74% sequentially from 2.39% in Q1 2026, and up 9372.0% YoY from 0.89% in Q2 2025.

CareDx (CDNA) Net Margin (2013 - 2026) Analysis & Trends

CareDx has reported Net Margin for 14 years, with the latest figure at 83.83% in Q2 2026.

Quarterly Net Margin rose 9372.0% year-over-year to 83.83% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 24.23% (up 718.0% YoY) and the FY2025 annual result came in at 5.62%, down 2137.0% from the prior year.
Net Margin improved to 83.83% in Q2 2026 per CDNA's latest filing, from 2.39% in the prior quarter.
Over five years, Net Margin peaked at 101.29% in Q4 2024 and troughed at 180.11% in Q4 2023.
A 5-year average of 14.38% and a median of 17.11% in 2022 frame the typical range for Net Margin.
The sharpest annual moves came in 2023 and 2024: Net Margin slumped 15786 bps in 2023, then surged 28140 bps in 2024.
Over 5 years, Net Margin stood at 22.25% in 2022, then sank by 710 bps to 180.11% in 2023, then soared by 156 bps to 101.29% in 2024, then sank by 104 bps to 3.79% in 2025, then soared by 2312 bps to 83.83% in 2026.
According to Business Quant data, Net Margin over the past three periods registered 83.83%, 2.39%, and 3.79% for Q2 2026, Q1 2026, and Q4 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Margin (Qtr)
1	Thermo Fisher Scientific	213.88 Bn	209.81 Bn	8.34 Bn	14.65%
2	Danaher	140.65 Bn	136.30 Bn	3.61 Bn	13.89%
3	Idexx Laboratories	46.02 Bn	45.83 Bn	779.09 Mn	27.82%
4	Agilent Technologies	39.85 Bn	38.05 Bn	990.00 Mn	18.47%
5	Iqvia Holdings	39.20 Bn	37.12 Bn	1.44 Bn	5.52%
6	Natera	38.80 Bn	37.70 Bn	696.04 Mn	-12.22%
7	Illumina	30.11 Bn	28.94 Bn	770.00 Mn	17.86%
8	Mettler Toledo International	28.66 Bn	28.61 Bn	650.22 Mn	22.67%
9	Quest Diagnostics	26.24 Bn	25.61 Bn	1.03 Bn	10.65%
10	CareDx	2.35 Bn	1.98 Bn	116.03 Mn	83.83%

Download Data